E-clinical Solution Software Market
E-clinical Solution Software Market - Global Industry Assessment & Forecast
Segments Covered
- By Product Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization & Trial Supply Management (RTSM), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (ECOA)
- By Delivery Mode Web-hosted (On Demand), Licensed Enterprise (On Premise), Cloud-based
- By Development Phase Phase I, Phase II, Phase III, Phase IV
- By End-Users Hospitals/Healthcare Providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 33.3 Billion |
Revenue 2030: | USD 210 Billion |
Revenue CAGR (2023 - 2030): | 30.1% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Sr. No. | Offering | Report Coverage |
1. | Market Size | In terms of Revenue (USD Million) |
2. | Historic Data | 2017 to 2021 |
3. | Forecast Data | 2023 to 2030 |
4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
5. | Market Attractiveness Analysis | Yes |
6. | Segment Analysis | Maximum Segments |
7. | Regional Coverage | 5 Regions |
8. | Country Coverage | Top 22 Countries |
9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
10. | Porter’s Five Forces Analysis | Yes. |
11. | Value Chain Analysis | Yes |
12. | PEST Analysis | Yes |
13. | Regulatory Landscape | Yes |
14. | Technology Landscape | Yes |
15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
16. | Top startups to watch out for | Yes |
17. | Top 3 Trends to Watch | Yes |
18. | Top 3 Strategies Followed by Major Players | Yes |
19. | Top 3 Predictions by Vantage Market Research | Yes |
20. | Discussion Guide | Yes |
21. | Key Primary Respondents - VERBATIM | Yes |
22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
23. | Others/Miscellaneous |
FAQ
Frequently Asked Question
What is the global demand for E-clinical Solution Software in terms of revenue?
-
The global E-clinical Solution Software valued at USD 33.3 Billion in 2022 and is expected to reach USD 210 Billion in 2030 growing at a CAGR of 30.1%.
Which are the prominent players in the market?
-
The prominent players in the market are Datatrak International Inc. (U.S.), Oracle (U.S.), Parexel International Corp. (U.S.), Dassault Systemes (France), Bioclinica (U.S.), CRF Health (U.S.), ERT Clinical (U.S.), eClinical Works (U.S.), IBM Watson Health (U.S.), Anju Life Sciences Software (India), eClinical Solutions (India).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 30.1% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the E-clinical Solution Software include
- Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the E-clinical Solution Software in 2022.